BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Influenza
,
Hypothalamus
,
Laryngoscope
,
Phenobarbital
,
TGFB1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neoadjuvant treatment
Summary
General Info
Curated Studies
Most Correlated Studies
ER+ breast carcinomas of postmenopausal women who responded to neoadjuvant Femara
Squamous cervical carcinoma patients after neoadjuvant chemotherapy - responders and non-responders
Bladder cancers treated with MVAC regimen as adjuvant or neoadjuvant therapies
Renal cell carcinoma from patients treated with neoadjuvant sunitinib
Resistance to neoadjuvant chemotherapy in HER2-negative breast cancer
Explore Curated Studies Results
Literature
Most Relevant Literature
Neoadjuvant therapy for potentially resectable pancreatic cancer: an emerging paradigm?
Pathological evaluation and grading for neoadjuvant therapy].
Neoadjuvant therapy for rectal cancer decreases the number of lymph nodes harvested in operative spe…
18F-FDG-PET evaluation of pathological tumour response to neoadjuvant therapy in patients with NSCLC…
Optimizing neoadjuvant therapy for rectal cancer with oxaliplatin.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Neoadjuvant Treatment of Locally-advanced Breast Cancer Patients With Ribociclib and Letrozole
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Pathological Response After Neoadjuvant Treatment on NSCLC
Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ